Introduction
============

The multifactorial and progressive nature of primary open angle glaucoma (POAG) is well established in regard to optic nerve damage and visual field (VF) loss ([@b35-co-2-757]; [@b24-co-2-757]; Hart et al 1997). Over time, 25% to 38% of patients exhibit signs of progression and ultimately blindness in one or both eyes ([@b35-co-2-757]; [@b24-co-2-757]; Hart et al 1997). A number of known risk factors associated with progression of vision loss and blindness in glaucoma patients is shown in [Table 1](#t1-co-2-757){ref-type="table"} ([@b28-co-2-757]; [@b12-co-2-757]; [@b32-co-2-757]; [@b15-co-2-757]; [@b11-co-2-757]; [@b19-co-2-757]; [@b5-co-2-757], [@b6-co-2-757]; [@b26-co-2-757]; [@b10-co-2-757]; [@b22-co-2-757]; [@b1-co-2-757]; [@b24-co-2-757]; [@b30-co-2-757], [@b31-co-2-757]; [@b2-co-2-757]; [@b27-co-2-757]; [@b14-co-2-757]; [@b8-co-2-757]; [@b17-co-2-757]; [@b33-co-2-757]; [@b34-co-2-757]; [@b21-co-2-757]; [@b25-co-2-757]; [@b3-co-2-757]).

However, it is not clear which of these factors are most important and which are influenced by variables such as fewer patients, short follow up, and ethnically non-diverse patient population. To determine risk factors for progression to blindness, we followed a large ethnically diverse patient population with high tension glaucoma over a long time frame. The primary outcome variable was the average percent of eyes that developed glaucoma-related blindness in either eye. Secondary outcome variables include sustained decrease of vision, progression of the disease, poor control, noncompliance, late detection, and level of intraocular pressure (IOP). Features of patients who developed blindness were compared with those who did not. The underlying hypothesis was that certain risk factors in such a diverse study population were not significant over the long term allowing us to identify the most critical clinical factors.

Materials and methods
=====================

Our cohort was selected from the patient population at an academic center, a county hospital, and a Veterans Affairs Hospital.

Legal blindness is defined in the US as visual acuity of 20/200 or worse and/or visual field less than 20° in the better eye ([@b29-co-2-757]). Since this study was designed to follow individual eyes, this definition of blindness was modified to refer to either eye rather than the better eye. The diagnosis of POAG included glaucomatous optic nerve cupping with corresponding VF defects, IOP ≥21 mmHg and open irido-corneal angle ([@b18-co-2-757]; [@b4-co-2-757]). Nine patients were blind in one eye at the start of the study. They were included because adequate long term information on the study variables were available. The exclusion criteria were: normal tension glaucoma (IOP \< 21 mmHg), secondary glaucoma, inability to maintain follow up for 3 months, eye conditions such as opaque media, macular degeneration, and vascular accidents that preclude diagnosis of glaucoma, and patients who were unable to perform ocular tests reliably. All eligible patients were examined and treated by the first author or by the eye residents and glaucoma fellows under direct supervision. The study protocol was approved by the appropriate Institutional Review Boards/Ethics Committees of the three clinics and adhered to the Declaration of Helsinki.

In all, 487 eligible patients (974 eyes) with POAG were enrolled in the study. The academic center (231 patients, 462 eyes) is a private patient facility attached to the University of Texas Southwestern Medical Center at Dallas. Parkland Memorial Hospital is a county hospital (98 patients, 196 eyes). The Dallas Veterans Affairs Hospital (158 patients, 316 eyes) is a federal government facility for United States veterans.

Measured continuous and categorical variables at the conclusion of the study are summarized in [Table 2](#t2-co-2-757){ref-type="table"}.

For this study, VF changes were recorded as stages: 1 = normal; 2 = relative scotoma outside 20°; 3 = absolute scotoma outside 20°; 4 = relative/absolute scotoma within 20°--10°; 5 = relative/absolute scotoma within 10°--5°; 6 = relative/absolute scotoma within 5° in 1--3 quadrants, 7 = relative/absolute scotoma within 5° in all quadrants ([@b16-co-2-757]). The criteria for VF abnormality on Humphrey program 30-2 full threshold strategy were a cluster of two or more adjacent points of 5-decibels (dB) or greater loss, and at least one of the points showing more than 10 dB loss according to the age corrected total deviation values. Every patient received one or more VF tests yearly. Optic nerve cupping was noted and drawn at baseline exam and at each visit. No photographs were taken. Any progression was flagged and reconfirmed by KSK or the glaucoma fellow. Features of optic disk progression were; progression of C/D ratio by ≥0.2, rim notching and thinning from baseline, and disk hemorrhage. Noncompliance was based on documented nonadherance to therapy/surgery or from two or more missed clinic appointments during the observation period. Poor control of glaucoma was based on the following features: use of three or more medications, requirement of laser or incisional surgery, progression of C/D ratio by ≥0.2, or progression of VF from one stage to the next. Late detection was defined as C/D disparity of ≥0.2 or VF loss of stage ≥3 in one or both eyes at initial presentation.

Categorical variables (such as gender, procedures, medications) of blindness and no-blindness groups were compared with the Fisher's Exact Test or Chi-square statistics. Continuous variables (such as age, C/D ratio) were compared between groups with two-sample t-tests or Wilcoxon Rank Sum tests if normality assumptions were not met. Logistic regression models were used to assess multiple risk factors simultaneously. Data management was performed using Microsoft Access 97 and 2000 (Microsoft Corp. Redmond, WA). For statistical analysis, SAS version 8.0 (SAS Institute, Cary, NC) was used.

Results
=======

At the end of the study, there were 282 (57.9%) nonblind patients and 205 (42.1%) blind patients. Of the total number of patients, 195 were diagnosed initially at one of the three study clinics. In the blind group, 120 (58.5%) had bilateral blindness while 85 (41.5%) had unilateral blindness. [Table 2](#t2-co-2-757){ref-type="table"} lists the main characteristics of the groups.

At baseline, the blind group had statistically significant higher IOP than the nonblind group (24.2 vs. 22.1 mmHg; p = 0.03). They also showed wide fluctuations (maximum to minimum IOP) over the course of the study (5.9 mmHg vs. 4.1 mmHg, p = 0.031). The mean IOP for each patient in both groups is shown in [Figure 1](#f1-co-2-757){ref-type="fig"}.

At pressure of 17 mmHg or less, 54 (26.3%) patients were blind. Pressure levels gradually decreased in both groups over time, but the standard deviation of individual IOP was still higher in the blind group (4.8 vs. 2.4 mmHg, p = 0.02).

Blind patients required more laser (43.4%), trabeculectomy (29.3%), and cyclodestruction (4.4%) procedures. Their vision at initial visit was also worse, with 76 (37%) recording vision ≤20/200 and only 93 (45.4%) showing vision of ≥20/40 compared with 261 (92.5%) of the non-blind group. By the last visit, 82 (40%) of blind subjects experienced deterioration of vision and 115 (56%) had dropped to ≤20/200. In comparison, only 36 (12.7%) of the nonblind group showed progression.

In blind individuals, the VF status at initial visit was: mild damage (stage 1 and 2) in 29 (14.2%); moderate damage (stage 3 and 4) in 49 (23.9%); and severe damage (stage 5 to7) in 127 (61.9%). At the final visit the values were 17 (8.3%), 41 (20.0%), and 147 (71.7%), respectively. VF deterioration occurred in 46 (16.3%) of nonblind group and 47 (22.9%) of blind group.

As expected, optic nerve appearance was worse in the blind group at first visit, with 154 (75%) of patients showing C/D of \>0.7 compared with 102 (36.2%) in the nonblind group. This figure reached 175 (85.4%) and 132 (46.8%) at the last visit, respectively. Both groups exhibited deterioration of optic nerve features. Similarly, noncompliance, inadequate control and late detection were higher in blind subjects. Baseline IOP, female gender, and baseline VF were significant risk factors for blindness ([Table 3](#t3-co-2-757){ref-type="table"}).

Other risk factors such as race, age, history of hypertension, diabetes, vascular disease, family history of glaucoma, smoking, alcohol abuse, systemic or topical steroids dysthyroidism, ocular trauma (all variables obtained by history) and myopia, were not significant.

Discussion
==========

Our findings support the widely held belief that IOP is still of paramount importance in management of glaucoma ([@b11-co-2-757]; [@b19-co-2-757]; [@b1-co-2-757]; [@b24-co-2-757]; [@b2-co-2-757]; [@b27-co-2-757]; [@b8-co-2-757]; [@b17-co-2-757]; [@b33-co-2-757]; [@b34-co-2-757]; [@b21-co-2-757]; [@b25-co-2-757]). Blind patients in our study had higher level of initial IOP, more fluctuations in pressure, and were difficult to control. Blindness and progression of glaucoma was evident at all pressure levels ([Figure 1](#f1-co-2-757){ref-type="fig"}). This finding is in contrast to the Advanced Glaucoma Intervention Study (AGIS) where progression was minimal in patients with IOP less than 18 mmHg. The AGIS investigators found that VF progression was less if a patient maintained IOP of less than 18 mmHg at each visit, but their patients had advanced glaucoma based on medical therapy where as this study had patients in all stages of the disease ([@b34-co-2-757]). At the final visit 116 (57%) patients had IOP \>21 mmHg. Why did so many patients have elevated mean IOP? There may be several explanations. First, some patients become noncompliant or exhibit poor response to therapy. Second, after an eye shows advanced VF loss such as split fixation, there is hesitancy to reduce IOP surgically for fear of "snuffing out" the remaining fibers ([@b19-co-2-757]). Third, when the visual acuity drops to HM or worse, IOP reduction becomes less of a priority compared with keeping the patient comfortable.

Similar to the findings of [@b21-co-2-757] our blind patients also required multiple medications and more laser and incisional surgeries. Subjects with blindness also presented with advanced visual acuity loss, VF loss, and optic nerve damage. Therefore, late detection was a significant risk factor. Moreover, a multivariate analysis using logistic regression to model the probability of blindness demonstrated that baseline elevated IOP and advanced VF damage were significant risk factors. Of those who were initially diagnosed with POAG at one of the three study clinics, blindness was detected at the first visit in 21.7%, which was similar to other studies ([@b26-co-2-757]; [@b10-co-2-757]; [@b20-co-2-757]). Several investigators have pointed out the role played by advanced VF damage at diagnosis ([@b12-co-2-757]; [@b11-co-2-757]; [@b19-co-2-757]; [@b27-co-2-757]; [@b17-co-2-757]; [@b25-co-2-757]; [@b3-co-2-757]), degree of VF loss in the worst eye ([@b17-co-2-757]), and vascular insufficiency ([@b28-co-2-757]; [@b32-co-2-757]; [@b5-co-2-757]; [@b8-co-2-757]). The progressive nature of POAG was evidenced by VF deterioration. Both noncompliance to treatment and inadequate control were more prevalent in blind patients. The significance of noncompliance with treatment has been stressed by several investigators ([@b5-co-2-757]; [@b20-co-2-757]). One weakness of the study is that the central corneal thickness was not measured because of the unavailability of measuring devices at the three centers. The authors understand the pivotal role central corneal thickness may play in the development and progression of glaucoma ([@b9-co-2-757]).

In conclusion, we followed 487 ethnically diverse patients with high tension POAG in a single metropolitan area and with a uniform management strategy for over 5 years. Risk factors for blindness were mainly pressure-elated: elevated initial IOP, wide variations and poor control of IOP, late detection of glaucoma, and noncompliance with therapy. Other known factors such as older age ([@b27-co-2-757]; [@b14-co-2-757]; [@b33-co-2-757]), black American ([@b30-co-2-757]; [@b15-co-2-757]), vascular insufficiency ([@b28-co-2-757]; [@b32-co-2-757]; [@b5-co-2-757]; [@b10-co-2-757]; [@b8-co-2-757]), or family history of glaucoma ([@b5-co-2-757]) were not significant. Our results suggest that further studies with larger diverse populations and longer follow are required to verify these findings and to better understand the dynamics of glaucoma progression.
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###### 

Risk factors for blindness in glaucoma

  IOP
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  -- Elevated IOP ([@b11-co-2-757]; [@b19-co-2-757]; [@b1-co-2-757]; [@b24-co-2-757]; [@b2-co-2-757]; [@b27-co-2-757]; [@b8-co-2-757]; [@b17-co-2-757]; [@b33-co-2-757]; [@b34-co-2-757]; [@b21-co-2-757]).
  -- Large diurnal variations ([@b34-co-2-757]; [@b25-co-2-757]).
  -- Poor control of IOP ([@b25-co-2-757]).
  -- Mean IOP in the better eye ([@b17-co-2-757]).
  Older age ([@b27-co-2-757]; [@b14-co-2-757]; [@b33-co-2-757]).
  Advanced VF damage at diagnosis ([@b12-co-2-757]; [@b19-co-2-757]; [@b10-co-2-757]; [@b22-co-2-757]; [@b27-co-2-757]; [@b25-co-2-757]; [@b3-co-2-757]).
  Black American ([@b15-co-2-757]; [@b30-co-2-757], [@b31-co-2-757]).
  Longer duration of disease ([@b10-co-2-757]).
  Noncompliance ([@b32-co-2-757]; [@b10-co-2-757]; [@b3-co-2-757]).
  Frequent disc hemorrhage ([@b6-co-2-757]).
  Late detection ([@b32-co-2-757]; [@b26-co-2-757]; [@b10-co-2-757]; [@b7-co-2-757]).
  Worse vision ([@b10-co-2-757]).
  Vascular insufficiency ([@b28-co-2-757]; [@b32-co-2-757]; [@b5-co-2-757]; [@b10-co-2-757]; [@b8-co-2-757]).
  Family history of glaucoma ([@b5-co-2-757]).
  Greater number of antiglaucoma medications ([@b21-co-2-757]).
  Glaucoma surgery ([@b21-co-2-757]).
  Higher socioeconomic class ([@b17-co-2-757]).
  VF loss in the worse eye ([@b17-co-2-757]).

**Abbreviations:** IOP, intraocular pressure; VF, visual field.

###### 

Demographics and characteristics of composite patient population: No blindness versus blindness

  Characteristics                                   No blindness n (%) 282          Blindness n (%) 205             p value
  ------------------------------------------------- ------------------------------- ------------------------------- ------------
  Age at diagnosis, yr (mean ± SD, median, range)   59.0 ± 12.6, 59.4, 21.2--86.9   59.3 ± 13.2, 61.1, 28.8--90.4   0.52
  Follow-up, yr (mean ± SD, median, range)          5.1 ± 3.1, 4.2, 1.0--18.1       6.1 ± 4.0, 5.2, 0.3--23.7       0.04
  Male                                              151 (53.5)                      139 (67.8)                      p \< 0.002
  Female                                            131 (46.4)                      66 (32.2)                       
  Caucasian                                         124 (44.0)                      69 (33.7)                       
  Black American                                    134 (47.4)                      119 (58.1)                      
  Hispanic                                          12 (4.3)                        7 (3.4)                         
  Other ethnicities                                 12 (4.3)                        10 (4.8)                        
  Ocular surgeries                                                                                                  
  Cataract                                          52 (18.4)                       48 (23.4)                       0.211
  ALT                                               92 (32.6)                       89 (43.4)                       0.020
  LPI                                               29 (10.3)                       31 (15.2)                       0.124
  Trabeculectomy                                    28 (9.9)                        60 (29.3)                       \<0.0001
  Combined                                          22 (7.8)                        18 (8.8)                        0.740
  Cyclodestruction                                  0 (0.0)                         9 (4.4)                         \<0.0004
  Others                                            14 (5.0)                        16 (7.8)                        0.252
  Visual acuity Deterioration                       36 (12.7)                       82 (40.0)                       \<0.0001
  VF progression                                    46 (16.3)                       47 (22.9)                       0.10
  IOP mmHg (mean ± SD, median, range)                                                                               
  Initial visit                                     22.1 ± 7.7, 21.0, 2--70         24.2 ± 11.2, 21.0, 2.0--70.0    0.030
  Final visit                                       18.1 ± 2.4, 18.0, 10.0--26.0    17.7 ± 4.8, 18.0, 0.0--46.0     0.153
  C/D ratio progression                             92 (32.6)                       55 (26.8)                       0.20
  Noncompliance                                     131 (46.4)                      129 (63.0)                      \<0.0003
  Poor control                                      207 (73.4)                      196 (95.6)                      \<0.0001
  Late detection                                    248 (87.9)                      195 (95.1)                      0.006

**Notes:** Blindness was defined as visual acuity of 20/200 or worse and/or visual field less than 20° in either eye.

**Abbreviations:** ALT, argon laser trabeculoplasty; LPI, laser peripheral iridotomy; CF, count fingers; HM, hand motion; LP, light perception; NLP, no light perception; VF, visual field; IOP, intraocular pressure; C/D, cup-to-disc; CAI, carbonic anhydrase inhibitor.

###### 

Multiple logistic regression analysis of the various variables and their effect on progression to blindness

  Parameter                                     Odds ratio   95% confidence limit for odds ratio   p value
  --------------------------------------------- ------------ ------------------------------------- -----------
  Age at diagnosis                              1.008        0.993--1.024                          0.281
  Race                                          1.148        0.919--1.435                          0.224
  Baseline IOP (\>22 mmHg vs. \<22 mmHg)        1.54         1.05--2.268                           0.028
  Clinic                                        1.157        0.905--1.478                          0.244
  Gender (female vs. male)                      0.601        0.383--0.943                          0.0268
  Baseline VF (1 scotoma or worse vs. normal)   13.698       4.863--38.582                         \<0.00001

**Abbreviations:** IOP, intraocular pressure; VF, visual field.
